Nevirapine Increases Sodium/Iodide Symporter-Mediated Radioiodide Uptake by Activation of TSHR/cAMP/CREB/PAX8 Signaling Pathway in Dedifferentiated Thyroid Cancer
Nevirapine has been proved to be effective in inducing re-differentiation and suppressing tumor growth in several tumor cells. This study aims to investigate the therapeutic potential of nevirapine in dedifferentiated thyroid cancer (DeTC), which refractory to radioiodine treatment and the underlyin...
Main Authors: | Hongxia Shang, Junyu Zhao, Jinming Yao, Huanjun Wang, Jianjun Dong, Lin Liao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.00404/full |
Similar Items
-
Nevirapine inhibits migration and invasion in dedifferentiated thyroid cancer cells
by: Hongxia Shang, et al.
Published: (2019-12-01) -
Downregulation of miR-146b-3p Inhibits Proliferation and Migration and Modulates the Expression and Location of Sodium/Iodide Symporter in Dedifferentiated Thyroid Cancer by Potentially Targeting MUC20
by: Shasha Hou, et al.
Published: (2021-01-01) -
Role of extrathyroidal TSHR expression in adipocyte differentiation and its association with obesity
by: Lu Sumei, et al.
Published: (2012-01-01) -
TSHR169 Antigen Specifically Binds to the Thyroid-stimulating Autoantibody, Representing an Effective Biomarker for Graves’ Disease
by: Zulkarnain Zulkarnain, et al.
Published: (2019-03-01) -
Transcription Factor CREB3L1 Regulates the Expression of the Sodium/Iodide Symporter (NIS) in Rat Thyroid Follicular Cells
by: Pablo Di Giusto, et al.
Published: (2022-04-01)